Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction
Condition: Heart Failure, Systolic Intervention: Drug: Sacubitril/valsartan Sponsor: National Institute of Cardiovascular Diseases, Karachi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2022 Category: Research Source Type: clinical trials
Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
Condition: Hypertrophic Cardiomyopathy Interventions: Drug: Sacubitril/Valsartan; Behavioral: Lifestyle Sponsors: Newcastle-upon-Tyne Hospitals NHS Trust; University Hospital Regensburg; Assistance Publique - Hôpitaux de Paris; Azienda Ospedaliero-Universitaria Careggi; Institute for Cardiovascular Diseases of Vojvodina Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2022 Category: Research Source Type: clinical trials